# BELSOMRA

NDC: 0006-0033
Generic name: suvorexant
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20140829

FDA application: NDA204569

## Active ingredients

- SUVOREXANT: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-0033"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-0033
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5b72731-1acb-45b7-9c13-290ad12d3951